Ishida Europe is launching its next generation IX-G2 dual energy X-ray inspection system which has increased the ability to detect bone fragments by a factor of four compared with previous X-ray models.The enhanced sensitivity of the machine also greatly reduces the risk of false detections, which helps to maximise throughput and avoids the costs associated with unnecessary waste and the repacking of proorganic vitamin c and zinc supplementductsThe high performance of the IX-G2-F is supported by Ishida’s unique self-learning Genetic Algorithm (GA) technology which combines with the new line sensor to deliver mais ferrous fumarate a good source of ironximum detection sensitivity and reliability. Ishida Europe is launching its next generation IX-G2 dual energy X-ray inspection system which has increased the ability to detect bone fragments by a factor of four compared with previous X-ray models.The GA technology focuses the X-ray machine to identify difficult to detect contaminants with a high degree of accuracy, even at high throughput rates, using image data analysis over a number of trial runs. As it is common in food production for similar contamination problems to recur, data logging can help to build up a more precise calibration protocol with each trial. This enables permanent or recurring defects to be easily identified during the inspection process.Ishida Europe is launching its next generation IX-G2 dual energy X-ray inspection system which has increased the ability to detect bone fragments by a factor of four compared with previous X-ray models.
Ishida’s dual energy technology incorporates two line sensors, one which takes images at high energymagnesium glycinate 400 mg and one at lferrous fumarate 200 mg dosageow energy. These are then compared, which provides a better overall image of the product with a clearer contrast between the product and any low-density foreign bodies, such as bone fragments.Ishida Europe is launching its next generation IX-G2 dual energy X-ray inspection system which has increased the ability to detect bone fragments by a factor of four compared with previous X-ray models.“The next generation IX-G2-F X-ray inspectionzinc bisglycinate for women system offers unrivalled performance and with its improved line sensor and software capabilities it has already delivered significant benefits on production lines,” comments Sibtain Naqvi, Ishida Europe’s X-ray Product Manager.